These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 24879628)

  • 1. Correlation between use of antiretroviral adherence devices by HIV-infected youth and plasma HIV RNA and self-reported adherence.
    Saberi P; Mayer K; Vittinghoff E; Naar-King S;
    AIDS Behav; 2015 Jan; 19(1):93-103. PubMed ID: 24879628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pillbox organizers are associated with improved adherence to HIV antiretroviral therapy and viral suppression: a marginal structural model analysis.
    Petersen ML; Wang Y; van der Laan MJ; Guzman D; Riley E; Bangsberg DR
    Clin Infect Dis; 2007 Oct; 45(7):908-15. PubMed ID: 17806060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors and Evolution of Antiretroviral Therapy Adherence Among Perinatally HIV-Infected Adolescents in Brazil.
    Côté J; Delmas P; de Menezes Succi RC; Galano E; Auger P; Sylvain H; Colson S; Machado DM
    J Adolesc Health; 2016 Sep; 59(3):305-310. PubMed ID: 27320032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Number of daily pills, dosing schedule, self-reported adherence and health status in 2010: a large cross-sectional study of HIV-infected patients on antiretroviral therapy.
    Gianotti N; Galli L; Bocchiola B; Cahua T; Panzini P; Zandonà D; Salpietro S; Maillard M; Danise A; Pazzi A; Lazzarin A; Castagna A
    HIV Med; 2013 Mar; 14(3):153-60. PubMed ID: 22994659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measuring Antiretroviral Adherence Among Young People Living with HIV: Observations from a Real-Time Monitoring Device Versus Self-report.
    Craker L; Tarantino N; Whiteley L; Brown L
    AIDS Behav; 2019 Aug; 23(8):2138-2145. PubMed ID: 30888573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Positive STEPS - a randomized controlled efficacy trial of an adaptive intervention for strengthening adherence to antiretroviral HIV treatment among youth: study protocol.
    Mimiaga MJ; Kuhns LM; Biello KB; Olson J; Hoehnle S; Santostefano CM; Hughto JMW; Safi H; Salhaney P; Chen D; Garofalo R
    BMC Public Health; 2018 Jul; 18(1):867. PubMed ID: 30001703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improving adherence and clinical outcomes through an HIV pharmacist's interventions.
    Ma A; Chen DM; Chau FM; Saberi P
    AIDS Care; 2010 Oct; 22(10):1189-94. PubMed ID: 20640958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiretroviral drug concentrations in hair are associated with virologic outcomes among young people living with HIV in Tanzania.
    Tabb ZJ; Mmbaga BT; Gandhi M; Louie A; Kuncze K; Okochi H; Shayo AM; Turner EL; Cunningham CK; Dow DE
    AIDS; 2018 Jun; 32(9):1115-1123. PubMed ID: 29438196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors associated with high rates of antiretroviral medication adherence among youth living with perinatal HIV in Thailand.
    Kang E; Delzell DA; Chhabra M; Oberdorfer P
    Int J STD AIDS; 2015 Jul; 26(8):534-41. PubMed ID: 25080289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of adherence monitoring tools and correlation to virologic failure in a pediatric HIV clinical trial.
    Intasan J; Bunupuradah T; Vonthanak S; Kosalaraksa P; Hansudewechakul R; Kanjanavanit S; Ngampiyaskul C; Wongsawat J; Luesomboon W; Apornpong T; Kerr S; Ananworanich J; Puthanakit T;
    AIDS Patient Care STDS; 2014 Jun; 28(6):296-302. PubMed ID: 24901463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiretroviral adherence and virologic suppression in partnered and unpartnered HIV-positive individuals in southern Brazil.
    de Melo MG; Varella I; Gorbach PM; Sprinz E; Santos B; de Melo Rocha T; Simon M; Almeida M; Lira R; Chaves MC; Baker Z; Kerin T; Nielsen-Saines K
    PLoS One; 2019; 14(2):e0212744. PubMed ID: 30811480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV-infected individuals with co-occurring bipolar disorder evidence poor antiretroviral and psychiatric medication adherence.
    Moore DJ; Posada C; Parikh M; Arce M; Vaida F; Riggs PK; Gouaux B; Ellis RJ; Letendre SL; Grant I; Atkinson JH;
    AIDS Behav; 2012 Nov; 16(8):2257-66. PubMed ID: 22041931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between viral load and self-report measures of medication adherence among youth with perinatal HIV infection.
    Usitalo A; Leister E; Tassiopoulos K; Allison S; Malee K; Paul ME; Smith R; Van Dyke RB; Seage GR; Mellins CA
    AIDS Care; 2014 Jan; 26(1):107-15. PubMed ID: 23800360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Realtime adherence monitoring of antiretroviral therapy among HIV-infected adults and children in rural Uganda.
    Haberer JE; Kiwanuka J; Nansera D; Muzoora C; Hunt PW; So J; O'Donnell M; Siedner M; Martin JN; Bangsberg DR
    AIDS; 2013 Aug; 27(13):2166-8. PubMed ID: 23751260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Barriers to medication adherence in behaviorally and perinatally infected youth living with HIV.
    MacDonell K; Naar-King S; Huszti H; Belzer M
    AIDS Behav; 2013 Jan; 17(1):86-93. PubMed ID: 23142855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive, academic, and behavioral correlates of medication adherence in children and adolescents with perinatally acquired HIV infection.
    Nichols SL; Montepiedra G; Farley JJ; Sirois PA; Malee K; Kammerer B; Garvie PA; Naar-King S;
    J Dev Behav Pediatr; 2012 May; 33(4):298-308. PubMed ID: 22366661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determinants of antiretroviral treatment adherence among HIV/AIDS patients: a multisite study.
    Tran BX; Nguyen LT; Nguyen NH; Hoang QV; Hwang J
    Glob Health Action; 2013 Mar; 6():19570. PubMed ID: 23497956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Examining the relationship between psychological distress and adherence to anti-retroviral therapy among Ugandan adolescents living with HIV.
    Mutumba M; Musiime V; Lepkwoski JM; Harper GW; Snow RC; Resnicow K; Bauermeister JA
    AIDS Care; 2016 Jul; 28(7):807-15. PubMed ID: 27294696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High turnaround times and low viral resuppression rates after reinforced adherence counselling following a confirmed virological failure diagnostic algorithm in HIV-infected patients on first-line antiretroviral therapy from Tanzania.
    Kroidl A; Burger T; Urio A; Mugeniwalwo R; Mgaya J; Mlagalila F; Hoelscher M; Däumer M; Salehe O; Sangare A; Lennemann T; Maganga L
    Trop Med Int Health; 2020 May; 25(5):579-589. PubMed ID: 31984634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for short-term virologic outcomes among HIV-infected patients undergoing regimen switch of combination antiretroviral therapy.
    Chao C; Tang B; Hurley L; Silverberg MJ; Towner W; Preciado M; Horberg M
    AIDS Res Hum Retroviruses; 2012 Dec; 28(12):1630-6. PubMed ID: 22475276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.